Updated:
Alix Ventures
Alix Ventures supports early stage Life Science startups engineering biology to drive radical advances in human health. The firm focuses on TechBio—melding...
Alix Ventures
Alix Ventures supports early stage Life Science startups engineering biology to drive radical advances in human health. The firm focuses on TechBio—melding technology and biology—and partners with founders to build transformative companies that impact the quality and effectiveness of patient care. Its team is built of Life Science founders, and it provides platform support including customer introductions, fundraising, and team building.
General information
Firm type
Venture Capital
Year founded
2019
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, United States
Principals
Chas Pulido
Founder & General Partner
Nick Goldner
Venture Partner
Mark Pulido
Operating Partner
Brian Fiske
SAB Member - Drug Development
Daniel Delubac
SAB Member - Diagnostics/Lab Services
Jake Becraft
SAB Member - Syn Bio / CGT
Frequently asked questions
Who runs investment decisions at Alix Ventures?
No named principals or investment committee members are identified in available sources.
Does Alix Ventures participate in fund commitments or only direct deals?
Available records list venture and growth strategies but provide no detail on fund commitments versus direct investments.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: